Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCW Biologics Inc.HCWB · Entity 8172 | Director | July 29, 2026 | July 31, 2026 |
| HOLOGIC INCHOLX · Entity 12463 | Director | March 14, 2024 | March 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCW Biologics Inc.
Report date July 29, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 41,644 |
Reported balance
After 2026-07-29 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-07-29 · Purchase · Acquired 7,736 · Balance 41,644 F1: The reporting person purchased these shares directly from the issuer in a private placement under a Securities Purchase Agreement dated July 29, 2026 ("SPA"), which purchase is exempt from the registration requirements of Section 5 of the Securities Exchange Act of 1934, as amended, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D thereunder. Additionally, the reporting person is entitled to receive common warrants exercisable for an aggregate of up to 7,736 shares of common stock. Under the terms of the SPA, issuance of the common warrants is subject to stockholder approval under Nasdaq Listing Rule 5635(d). Upon issuance, the common warrants will be exercisable immediately and expire 5.5 years from date of issuance. F2: Mr. Garrett is deemed to beneficially own the shares held by Garrett Capital Partners, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person purchased these shares directly from the issuer in a private placement under a Securities Purchase Agreement dated July 29, 2026 ("SPA"), which purchase is exempt from the registration requirements of Section 5 of the Securities Exchange Act of 1934, as amended, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D thereunder. Additionally, the reporting person is entitled to receive common warrants exercisable for an aggregate of up to 7,736 shares of common stock. Under the terms of the SPA, issuance of the common warrants is subject to stockholder approval under Nasdaq Listing Rule 5635(d). Upon issuance, the common warrants will be exercisable immediately and expire 5.5 years from date of issuance.
F2: Mr. Garrett is deemed to beneficially own the shares held by Garrett Capital Partners, LLC.
HOLOGIC INC
Report date March 14, 2024 · Filed March 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,611 |
Last balance in matching sequence
After 2024-03-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2024-03-14 · Exercise / conversion · Acquired 9,039 · Balance 57,650 F1: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Row 2 · 2024-03-14 · Exercise / conversion · Acquired 7,402 · Balance 65,052 F1: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Row 3 · 2024-03-14 · Sale · Disposed 16,441 · Balance 48,611 F1: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.74 · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2024-03-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-14 · Exercise / conversion · Disposed 9,039 · Balance 0 |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.04 · Expires 2026-03-02 | Direct | 0 |
Reported balance
After 2024-03-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-14 · Exercise / conversion · Disposed 7,402 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 31, 2026 20:02 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock | 7,736 | $2.59 | $19,997.56 |
DisclosureSEC source: 0001493152-26-035619 · ownership.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 41,644 F1 · kind: The reporting person purchased these shares directly from the issuer in a private placement under a Securities Purchase Agreement dated July 29, 2026 ("SPA"), which purchase is exempt from the registration requirements of Section 5 of the Securities Exchange Act of 1934, as amended, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D thereunder. Additionally, the reporting person is entitled to receive common warrants exercisable for an aggregate of up to 7,736 shares of common stock. Under the terms of the SPA, issuance of the common warrants is subject to stockholder approval under Nasdaq Listing Rule 5635(d). Upon issuance, the common warrants will be exercisable immediately and expire 5.5 years from date of issuance. F2 · ownership.nature: Mr. Garrett is deemed to beneficially own the shares held by Garrett Capital Partners, LLC. Read SEC document |
| May 22, 2026 Filed May 27, 2026 23:25 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock Purchase Warrant · Derivative | 177,936 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001493152-26-025476 · ownership.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 180,628 Underlying: Common Stock · 177,936 shares Expires 2031-11-22 F1 · kind: The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 22, 2026 Filed May 27, 2026 23:25 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock | 177,936 | $1.41 | $250,000.08 |
DisclosureSEC source: 0001493152-26-025476 · ownership.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 203,441 F1 · kind: The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:34 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock | 13,423 | $7.45 | $100,001.35 |
DisclosureSEC source: 0000950170-25-075252 · ownership.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,505 F1 · shares: These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company. Read SEC document |
| May 08, 2025 Filed May 9, 2025 21:31 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock | 5,385 | $26.00 | $140,010.00 |
DisclosureSEC source: 0000950170-25-068287 · ownership.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,082 F1 · kind: These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025, along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company. Read SEC document |
| May 07, 2025 Filed May 9, 2025 21:31 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock Purchase Warrant · Derivative | 2,692 | $0.00 Strike: $26.00 | $0.00 |
DisclosureSEC source: 0000950170-25-068287 · ownership.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,692 Underlying: Common Stock · 2,692 shares Expires 2030-05-07 F1 · kind: These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025, along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:58 UTC | HCW Biologics Inc. HCWB · Entity 8172 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000950170-24-074336 · ownership.xml · derivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-13 F1 · derivative.exercise_date: (1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:11 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 7,402 | $0.00 Strike: $36.04 | $0.00 |
DisclosureSEC source: 0001127602-24-010261 · form4.xml · derivative · entry 5 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,402 shares Expires 2026-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:11 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 9,039 | $0.00 Strike: $26.74 | $0.00 |
DisclosureSEC source: 0001127602-24-010261 · form4.xml · derivative · entry 4 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,039 shares Expires 2025-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:11 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 16,441 | $75.50 | $1,241,295.50 |
DisclosureSEC source: 0001127602-24-010261 · form4.xml · nonDerivative · entry 3 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,611 F1 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:11 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 7,402 | $36.04 | $266,768.08 |
DisclosureSEC source: 0001127602-24-010261 · form4.xml · nonDerivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:11 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 9,039 | $26.74 | $241,702.86 |
DisclosureSEC source: 0001127602-24-010261 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:51 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,536 | $0.00 Strike: $76.32 | $0.00 |
DisclosureSEC source: 0001127602-24-009438 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,536 Underlying: Common Stock · 4,536 shares Expires 2034-03-07 F4 · derivative.exercise_date: Options become exercisable on the date of the 2025 Annual Meeting of Stockholders. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:51 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-009438 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,611 F1 · shares: Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 19:21 UTC | HCW Biologics Inc. HCWB · Entity 8172 | GrantCommon Stock | 142,858 | $1.40 | $200,001.20 |
DisclosureSEC source: 0001209191-24-003784 · doc4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 267,858 F1 · kind: The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:07 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 10,000 | $68.71 | $687,116.00 |
DisclosureSEC source: 0001127602-23-029562 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,039 F1 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $68.67 to $68.77 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:03 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 10,000 | $79.72 | $797,240.00 |
DisclosureSEC source: 0001127602-23-019032 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,039 F1 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $79.65 to $79.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 21:14 UTC | HCW Biologics Inc. HCWB · Entity 8172 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-23-037428 · doc4.xml · derivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-12 F1 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2024 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:14 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,210 | $0.00 Strike: $78.49 | $0.00 |
DisclosureSEC source: 0001127602-23-009868 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,210 Underlying: Common Stock · 4,210 shares Expires 2033-03-09 F4 · derivative.exercise_date: Options become exercisable on the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:14 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-009868 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,039 F1 · kind: Represents restricted stock units which vest on the date of the 2024 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:15 UTC | HCW Biologics Inc. HCWB · Entity 8172 | GrantStock Option (Right to Buy) · Derivative | 41,841 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001209191-22-037846 · doc4.xml · derivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,841 Underlying: Common Stock · 41,841 shares Expires 2032-06-14 F1 · derivative.exercise_date: 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2023 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:23 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,293 | $0.00 Strike: $70.28 | $0.00 |
DisclosureSEC source: 0001127602-22-009131 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,293 Underlying: Common Stock · 5,293 shares Expires 2032-03-10 F4 · derivative.exercise_date: Options become exercisable on the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:23 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009131 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,574 F1 · shares: Represents restricted stock units which vest on the date of the 2023 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 23:32 UTC | HCW Biologics Inc. HCWB · Entity 8172 | PurchaseCommon Stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0001209191-21-048084 · doc4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 125,000 F1 · shares: Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share. Read SEC document |
| July 22, 2021 Filed Aug 27, 2021 20:43 UTC | HCW Biologics Inc. HCWB · Entity 8172 | GrantStock Option · Derivative | 20,964 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001209191-21-053635 · doc4.xml · derivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,964 Underlying: Common Stock · 20,964 shares Expires 2031-07-21 F1 · derivative.exercise_date: The option will fully vest on July 22, 2022. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:13 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,055 | $0.00 Strike: $71.03 | $0.00 |
DisclosureSEC source: 0001127602-21-010622 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Underlying: Common Stock · 5,055 shares Expires 2031-03-11 F4 · derivative.exercise_date: Option becomes exercisable on the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:13 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,478 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010622 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,009 F1 · shares: Represents restricted stock units which vest on the date of the 2022 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,146 | $0.00 Strike: $22.35 | $0.00 |
DisclosureSEC source: 0001127602-20-028793 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,146 shares Expires 2021-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 11,146 | $22.35 | $249,113.10 |
DisclosureSEC source: 0001127602-20-028793 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:16 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 24,204 | $0.00 Strike: $20.34 | $0.00 |
DisclosureSEC source: 0001127602-20-015416 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,204 shares Expires 2020-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:16 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 24,204 | $20.34 | $492,309.36 |
DisclosureSEC source: 0001127602-20-015416 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. F2 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:03 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,322 | $0.00 Strike: $47.36 | $0.00 |
DisclosureSEC source: 0001127602-20-009971 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,322 Underlying: Common Stock · 7,322 shares Expires 2030-03-05 F4 · derivative.exercise_date: Options become exercisable on the date of the 2021 Annual Meeting of Stockholders. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:03 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 2,217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-009971 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,181 F1 · shares: Represents restricted stock units which vest on the date of the 2021 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 20:28 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 6,523 | $0.00 Strike: $46.81 | $0.00 |
DisclosureSEC source: 0001127602-19-010808 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,523 Underlying: Common Stock · 6,523 shares Expires 2029-03-07 F4 · derivative.exercise_date: Options become exercisable on the date of the 2020 Annual Meeting of Stockholders Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 20:28 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 2,136 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-010808 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,964 F1 · shares: Represents restricted stock units which vest on the date of the 2020 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:24 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,551 | $0.00 Strike: $38.44 | $0.00 |
DisclosureSEC source: 0001127602-18-011831 · form4.xml · derivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,551 Underlying: Common Stock · 7,551 shares Expires 2028-03-14 F4 · derivative.exercise_date: Options become exercisable on the date of the 2019 Annual Meeting of Stockholders. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:24 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 2,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-011831 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,828 F1 · shares: Represents restricted stock units which vest on the date of the 2019 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 4,633 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionRestricted Stock Unit Award (Right To Receive) · Derivative | 2,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011076 · form4.xml · derivative · entry 4 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis upon vesting. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. F5 · derivative.exercise_date: These RSUs vest and convert into shares of common stock on the date of the 2017 Annual Meeting of Stockholders. F5 · derivative.expiration_date: These RSUs vest and convert into shares of common stock on the date of the 2017 Annual Meeting of Stockholders. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 6,816 | $0.00 Strike: $41.92 | $0.00 |
DisclosureSEC source: 0001127602-17-011076 · form4.xml · derivative · entry 3 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,816 Underlying: Common Stock · 6,816 shares Expires 2027-03-08 F4 · derivative.exercise_date: Options become exercisable on the date of the 2018 Annual Meeting of Stockholders. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 2,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011076 · form4.xml · nonDerivative · entry 2 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. F3 · balance_after: Includes 2,427 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 2,206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011076 · form4.xml · nonDerivative · entry 1 GARRETT SCOTT T · CIK 0001231174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,995 F1 · shares: Represents Restricted Stock Units (RSUs) which vest on the date of the 2018 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.